Jupiter Neurosciences JUNS
NASDAQ JUNS
$2.57 +0.13 (+5.63%)
As of: Oct 1, 2026 · 9:59 AM EDT

Jupiter Neurosciences (JUNS) Current Deferred Revenue (2025 - 2026)

Updated

Jupiter Neurosciences (JUNS) reported Current Deferred Revenue of $859.00 for Q2 2026.

Analysis

Jupiter Neurosciences (JUNS) Current Deferred Revenue (2025 - 2026) Analysis & Trends

At the end of FY2025, Jupiter Neurosciences posted Current Deferred Revenue of $735.00.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Procter & Gamble 337.81 Bn 293.80 Bn 10.28 Bn
2 Colgate Palmolive 68.01 Bn 63.06 Bn 3.30 Bn
3 Kenvue 33.93 Bn 29.54 Bn 2.30 Bn
4 Estee Lauder Companies 33.63 Bn 21.70 Bn 2.74 Bn
5 Kimberly Clark 32.41 Bn 29.73 Bn 1.60 Bn
6 Church & Dwight 22.35 Bn 20.88 Bn 693.90 Mn
7 Clorox 9.80 Bn 8.24 Bn 804.00 Mn
8 e.l.f. Beauty 5.95 Bn 4.92 Bn 398.84 Mn
9 Reynolds Consumer Products 4.56 Bn 4.22 Bn 245.00 Mn
10 Jupiter Neurosciences 1.62 Mn -6.29 Mn 21,064.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 859.00
Dec 31, 2025 735.00
Sep 30, 2025 6,695.00
API Access

Jupiter Neurosciences Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=JUNS&period=max&api_key=YOUR_API_KEY